Search Results
Elisabeth M. Paietta, PhD, Defines Minimum Residual Disease
Minimum Residual Disease in Acute Lymphoblastic Leukemia
Dr. Litzow on Assessing Minimal Residual Disease in Patients With ALL
Significance of Minimal Residual Disease in Acute Myeloid Leukemia
Dr. Durie on a More Sensitive Automated Flow Cytometry MRD Test
Monitoring Response and Defining Complete Remission in Multiple Myeloma
MRD Evaluation in Myeloma: A necessary clinical tool?
Leukaemia Research - MRD Test - 10 minute film
Thomas P. Loughran, Jr, MD Discusses the Clinical Challenges and Therapeutic Approaches
Yale ASH 2022 Highlights: Myeloid Leukemia
SS08 Foregut II: S041 LAPAROSCOPIC GASTRECTOMY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
Post-Chemotherapy Robot-assisted Laparoscopic Resection
